Article and Video CATEGORIES

Cancer Journey

Search By

RET in Lung Cancer: The Next Big Target?
Please Note: While this is Still Excellent Background Info, New Treatments and Procedures Have Emerged Since this Original Post
Author
GRACE Videos and Articles
Image

A trial studying Cometriq (cabozantinib) for RET rearrangements showed a promising response rate, which led the doctors to discuss if they think RET is going to be the next actionable target in lung cancer.

 

Please feel free to offer comments and raise questions in our Discussion Forums.

 

Next Previous link

Previous PostNext Post

Related Content

Online Community

Hi James Anthony, I'm so sorry you are going through this and so very young.  It' s true that some people benefit for years with chemo and targeted therapies.  With the...

Hi siigs, I'm sorry you're having health issues. They don't sound like pancoast tumor symptoms.  A consult with a pulmonologist can help to understand your chest symptoms and work toward alleviating...

Hi Lonnie, 

Yes, the info in last year's OncTalk was up to date at that moment.  I think it would be well worth the watch along with videos in our 2025...

Hello Natalieaster, Welcome to Grace.  I hope your stay with us is short, but we are always here to answer, listen and share.  

Since your doctor didn't seem too worried...

Recent Comments

JOIN THE CONVERSATION
ROS 1
By JanineT GRACE … on
Hi siigs, I'm sorry you're…
By JanineT GRACE … on
Tomorrow Saturday, Oct. 25, 2025
By JanineT GRACE … on
Blood Cancers OncTalk-Live, Free, Learn Sat. Oct. 25
By JanineT GRACE … on